Certis Oncology, an AI-enabled translational science company, today announced the launch of Certis Oncology Intelligence ®, an integrated platform designed to generate data-driven insights into ...

Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 /Champions Oncology, Inc.

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel ...

Expanding data licensing and analytics services, coupled with global cancer prevalence, drive adoption, offering advanced treatment planning and improved patient outcomes AI in Oncology for Analytical ...

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

As hospitals reduced their spending on oncology treatments due to the increasing availability of biosimilars, the reimbursements they received from insurers did not drop at the same rate—allowing h | ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

Safety and QoL considerations are reshaping sequencing, including avoidance of immunotherapy in certain drivers and adoption ...

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has been awarded a prestigious ...

Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred ...

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how ...

BOCA RATON, Fla.-- (BUSINESS WIRE)--Mar 27, 2026-- ...